Home > Archive for News

Nanny Angel Network the grand prize winner of Astellas Oncology 2019 C3 Prize® to Improve Cancer Care

Astellas Pharma US, Inc. (“Astellas”) today announced it has awarded $200,000 in total grants and resources to winners of the fourth annual C3 (Changing Cancer Care) Prize, a challenge that funds the best ideas beyond medicine to improve cancer care for patients, caregivers and their loved ones. Audrey Guth, founder of Nanny Angel Network in Toronto, Canada, was chosen as the 2019 Grand Prize winner.

With the funds from the C3 Prize, Guth intends to expand the reach and impact of Nanny Angel Network, which trains volunteers to care for children whose mothers have cancer. Guth, a cancer survivor and mother of four, established the Nanny Angel Network in 2009 after she found a gap in healthcare and social services for mothers with cancer and their children. The program provides stability, normalcy, and support during a challenging time.

“Moms, particularly in underserved populations, are often forced to choose between caring for their children and going for treatment, and such a serious diagnosis can leave kids feeling sad, scared and anxious,” Guth said. “I am grateful for the opportunity to expand the reach and impact of Nanny Angel Network as we seek to ease the burden of living with cancer for families.”

Leah Werry represents Nanny Angel Network at the Astellas Oncology C3 Prize finals

Three finalists pitched their ideas to a panel of judges, including celebrity entrepreneur and cancer activist Bill Rancic and other leaders in innovation, healthcare and business, during a live pitch event in New York on October 25, 2019. Leah Werry, Kingston Champion of Nanny Angel Network, pitched on Guth’s behalf.

“As the husband of a cancer survivor, a father and a businessman, it is an honor to help select the winning idea and put a spotlight on life-changing cancer care solutions,” Rancic said. “This winning idea is putting the focus on families and providing critical stability for families throughout the ups and downs of a cancer journey.”

This year’s challenge awarded four prizes totaling $200,000 in funds (one Grand Prize of $100,000, two $45,000 Innovation Prizes, and one Emerging Ideas Prize of $10,000). Along with the funding, all winners will have the opportunity to attend TEDMED 2020 as TEDMED Scholars, joining a unique, multidisciplinary community of leading thinkers and doers from across the landscape of health, medicine, and scientific innovation. The winners also will receive a yearlong complimentary membership to MATTER, a global healthcare startup incubator, community nexus and corporate innovation accelerator.

The 2019 Innovation Prize winners are:

  • Daniella Koren of New York, New York, USA, founder of Arches Technology, whose idea is to expand a digital patient education and engagement program called MyCareCompass that provides relevant information and evidence-based education to people impacted by cancer throughout their treatment journey.
  • Leslie Schover of Houston, Texas, USA, founder of Will2Love, whose idea is to tailor self-help programs for men and women to meet the needs of special populations including younger survivors and LGBTQ survivors. Will2Love provides online education and expert guidance to help people impacted by cancer overcome problems with sexual health and fertility, trains oncology professionals to better manage these problems, and consults to hospitals to set up reproductive health programs.

This year, Astellas introduced a new Emerging Ideas Prize to recognize ideas that need additional cultivation before implementation. Abby Westerman of b-present Foundation was selected for this prize and also presented at the live pitch event. Westerman plans to use the Emerging Ideas Prize to extend the reach of b-there, a web-based patient and supporter connection tool to lower the barrier for young adults with cancer to stay connected with friends, offering a quick, easy, low-stress way to control visits, convey status updates, and request needed items.

“Astellas is extremely proud to help advance the inspiring ideas from this year’s winners, who are actively working to transform what it means to live with a cancer diagnosis, and improve the patient experience throughout the cancer journey,” said Mark Reisenauer, senior vice president, Oncology Business Unit at Astellas.

For more information, visit www.C3Prize.com.

About the Astellas Oncology C3 Prize
The Astellas Oncology C3 Prize, launched in 2016, is a global challenge that aims to address the complexities of the cancer journey by funding the best ideas in cancer care beyond medicine. The C3 Prize sparks innovative developments in cancer care, tackling cancer challenges by awarding the winners with prize money and connecting them with resources and support. The C3 Prize directly reflects the mission of Astellas Oncology: striving to make every day better for those impacted by cancer. Astellas maintains no ownership in the ventures funded by the C3 Prize. For more information, visit the website at https://www.C3Prize.com.

About Astellas
Astellas is a pharmaceutical company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products. For more information on Astellas, please visit our website at http://www.astellas.us. You can also follow us on Twitter at @AstellasUS, Facebook at http://www.facebook.com/AstellasUS or LinkedIn at http://www.linkedin.com/company/astellas-pharma.

About TEDMED
TEDMED is the independent health and medicine edition of the world-famous TED conference and TED Talks, dedicated to “ideas worth spreading.” TEDMED bridges the gap between science and the public by finding and sharing stories that inform, inspire, engage, and provoke action across a broad, passionate community both inside and outside of health and medicine. Best known for their annual event, TEDMED is a year-round global community. TEDMED is a 501(c)(3) Public Charity.

About MATTER
MATTER is a global healthcare startup incubator, community nexus and corporate innovation accelerator. MATTER mobilizes a community of entrepreneurs, industry innovators, scientists and clinicians committed to improving health and care for every patient.

SOURCE Astellas Pharma US, Inc.

Nanny Angel Network heads to New York City as a finalist for the Astellas Oncology C3 grand prize

(TORONTO, ON – October 9, 2019) – Astellas Pharma US announced the three finalists for its fourth annual C3 (Changing Cancer Care) Prize, a challenge that funds the best ideas beyond medicine to improve cancer care for patients, caregivers and their loved ones.

Nanny Angel Network is thrilled to announce that we have been selected as one of only three finalists for this prestigious award. We are the only Canadian organization selected as a finalist to compete in the final event.

The three grand prize finalists, including NAN, will pitch their ideas to a panel of judges on October 25 during a live event in New York City. NAN’s Kingston Champion Leah Werry will travel to NYC to represent us at the C3 Prize-partner TEDMED event.  

The Astellas Oncology C3 Prize launched in 2016 as a global challenge that aims to address the complexities of the cancer journey by funding the best ideas in cancer care beyond medicine. Nanny Angel Network is proud to be recognized for our existing work to fill the gaps in health and social care and should we win, the Astellas C3 Prize funding will help us in our goal to lessen the impact of cancer on families across Canada and beyond.

More details on how to watch the C3 Prize TEDMED presentation will be shared as we learn them. Please visit www.c3prize.com to learn more about this award.

A Network of Angels

Dolce Magazine featured Audrey Guth, Founder of the Nanny Angel Network in their Fall 2018 issue. Audrey speaks about her experience with cancer and what inspired her to create the Nanny Angel Network.

When someone tells you that you have cancer, it is a huge shock. That’s what happened to Audrey Guth. “When I was diagnosed with cancer, it rocked my world,” she says. “You know, everyone feels somewhat omnipotent, and you think, ‘It’s not going to be me.’ And yet, it was me.”

Thank you to Dolce Magazine for raising awareness of NAN.

Read the article.

 

‘Nanny Angels’ help single mother with cancer care for 4-year-old son

Abeer Salim is fighting for her life. A single mother in the late stages of terminal cancer, she says her treatments and chemotherapy often leave her so drained that she cannot get out of bed, let alone do the one thing the brightens her day the most — play with her young son.

For months now, she has relied on friends to watch four-year-old Mohamed as she battles to reclaim her health. But like many who juggle the roles of young mother and cancer patient, she has found her energy can only take her so far.

Keep Reading